During the past decade, Blue Ridge Medical Research conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 20 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 17 clinical trials were completed. i.e. 94.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Blue Ridge Medical Research" #1 sponsor was "Exact Sciences Corporation" with 7 trials, followed by "Pfizer" with 6 trials sponsored, "Celgene" with 5 trials sponsored, "Allergan" with 4 trials sponsored and "Shire" with 4 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Blue Ridge Medical Research" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 4 trials as a collaborator, "Allergan Sales, LLC" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Blue Ridge Medical Research" are "Colorectal Cancer" (9 trials), "Ulcerative Colitis" (6 trials), "Eosinophilic Esophagitis" (4 trials), "Colorectal Neoplasms" (3 trials) and "Crohn Disease" (3 trials). Many other conditions were trialed in "Blue Ridge Medical Research" in a lesser frequency.

Most popular intervention types in "Blue Ridge Medical Research" are "Drug" (32 trials), "Other" (6 trials), "Diagnostic Test" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Etrasimod" (6 trials), "Ozanimod" (3 trials), "Vonoprazan" (3 trials) and "CC-93538" (2 trials). Other intervention names were less common.

The vast majority of trials in "Blue Ridge Medical Research" are 42 trials for "All" genders.

Currently, there are NaN active trials in "Blue Ridge Medical Research". undefined are not yet recruiting, 11 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Blue Ridge Medical Research, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Blue Ridge Medical Research, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".